Hormone Contraceptives in Special Populations Flashcards
Bariatric Surgery Patients
-Pertains only to those who’ve had malabsorptive surgery (bilopancreatic diversion and Roux-en-Y), NOT restrictive surgery
- Avoid oral contraceptives
- Recommend vaginal ring, patch or injection
Breast Cancer Patients
Current or history of breast cancer should not use hormone contraceptives
No restrictions for benign or family hx of breast disease
Diseases Treated with Antiepileptics or Antiretroviral
-Avoid hormone contraceptives in those taking phenyoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine
-Those on lamotrigine = can take POPS
(Estrogen decreases lamotrigine levels by 50%)
-Those on protease inhibitor fosamprenavir can take POPs and injections
Depression Patients
- Avoid progestins as it may exacerbate depression (esp the inj progestin cause it is long acting)
- Most other hormone contraceptives may be used
Diabetic Patients
Hormone contraceptives may impair glucose and carbohydrate metabolism
- Avoid combination hormone contraceptives for those with diabetes + nephropathy, retinopathy, neuropathy, or vascular
- Avoid combination hormone contraceptives for those with diabetes for over 20 years
- Recommend Progestin only products for these patients
History of VTE
-Avoid combined hormone contraceptives
Hepatic Dysfunction Patients
-Acute hepatitis, liver cancer, cirrhosis, hx of gallbladder disease, cholestasis = Avoid combined hormone contraceptives
Migraine Patients
- Migraines with Aura = Avoid combined hormone contraceptives; use Progestin only products
- Migraines without aura = can use CHC or Progestin only products
Lupus Patients with positive or unknown antiphospholiid antibody test
-Avoid hormone contraceptives altogether because antiphospholipid antibodies can increase risk of ischemic heart disease, stroke, VTe
Rheumatoid Arthritis Patients
- Avoid injections because of risks of fractures
- Consider oral hormone contraceptives OR Progestin only products for RA pts also on steroids
Postpartum and Breastfeeding Patients
Hypercoagulable for 21 days after childbirth is
-Avoid combined hormone contraceptives within 21 days postpartum, but can use Progestin only products or injection
After 21 Days postpartum…
-Breastfeeding = Progestin only products preferred.
(21-30 days) = those at high risk for BRE should avoid CHCs, otherwise all other hormone contraceptives may be used
(After 42 days) = all hormone contraceptives can be used
-Non-Breastfeeding = (21-42 days) postpartum CHCs are not recommended in those with risk factors for VTE, otherwise if no high risk factors then can use any hormone contraceptives
Ischemic Heart Disease & Stroke
- Those with current or history of IHD or stroke should not use combined hormone contraceptives or injection
- May consider progestin only products but D/C if ischemic symptoms worsen
HTN and HLD Patients
- HTN = Avoid combined hormone contraceptives; use progestin only products or injection
- HLD = can use combined hormone contraceptives if no risk for other cardiovascular factors or severe genetic lipid disorders that increases risk of cardiovascular disease
Characteristics that Increase the Risk of VTE with CHCs
Smoking, Age 35+, Obesity (BMI >30), Recent major surgery
- Smoking + age <35 yrs = May use CHCs, POPs or inj. (max dose of ethinyl estradiol <50mcg)
- Smoking + age > 35 yrs = Avoid CHCs. May use POPs or inj
- Obesity = May use CHCs, POPs or inj. (max dose of ethinyl estradiol <50mcg). Avoid CHC patch in women >198 lbs
- Recent surgery w/ prolonged immobility = Avoid CHCs. May use POPs or inj.